Beilu Pharmaceutical (300016.SZ) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 114 million, up 157.83% year on year.

Zhitong Finance APP News, Beilu Pharmaceutical (300016.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.059 billion yuan, a year-on-year increase of 21.30%. Net profit attributable to shareholders of the listed company was 114 million yuan, a year-on-year increase of 157.83%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 101 million yuan, a year-on-year increase of 200.55%.